(Q36441745)

14 August 2017

1 reference

title

Immortalizing genes of Epstein-Barr virus (English)

1 reference

14 August 2017

Immortalizing Genes of Epstein-Barr Virus (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

23 October 2022

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659776

23 October 2022

viral genes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659776

23 October 2022

author name string

T. Middleton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659776

23 October 2022

T. A. Gahn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659776

23 October 2022

J. M. Martin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659776

23 October 2022

B. Sugden

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659776

23 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1659776

23 October 2022

publication date

1 January 1991

1 reference

Advances in Virus Research

14 August 2017

1 reference

14 August 2017

40

1 reference

14 August 2017

19-55

1 reference

Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.

14 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Replication of latent Epstein-Barr virus genomes in normal and malignant lymphoid cells

23 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus latent gene expression during the initiation of B cell immortalization

23 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus-transformed pro-B cells are prone to illegitimate recombination between the switch region of the mu chain gene and other chromosomes

23 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA

23 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B.

23 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

23 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus

23 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

A New Approach to the Study of Human B Lymphocyte Function Using an Indirect Plaque Assay and a Direct B Cell Activator

23 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus mRNAs produced by alternative splicing

23 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding

23 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Identification of an origin of bidirectional DNA replication in mammalian chromosomes

23 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

fgr proto-oncogene mRNA induced in B lymphocytes by Epstein-Barr virus infection

23 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication

23 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

23 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids

23 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

23 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Direct T helper-B cell interactions induce an early B cell activation antigen

23 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2

23 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation

23 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Transcriptional elements as components of eukaryotic origins of DNA replication

23 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

23 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Progenitor and pre-B lymphocytes transformed by Epstein-Barr virus

23 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element

23 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

23 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication

23 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA

23 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies.

23 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line

23 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Down-regulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells

23 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes

23 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

23 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels

23 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Replication of the resident repressed Epstein-Barr virus genome during the early S phase (S-1 period) of nonproducer Raji cells

23 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Return of the magnificent seven

23 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells

23 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Efficiency of transformation of lymphocytes by Epstein-Barr virus

23 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection

23 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites

23 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements

23 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Isolation and oncogenic potential of a novel human src-like gene

23 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

High-resolution footprints of the DNA-binding domain of Epstein-Barr virus nuclear antigen 1.

23 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

The structure of the termini of the DNA of Epstein-Barr virus

23 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein–Barr virus

23 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Viral latency and transformation: the strategy of Epstein-Barr virus

23 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Expression of the c-fgr related transcripts in Epstein-Barr virus-associated malignancies

23 October 2022

58

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx

23 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Establishment of Anti-TNP Antibody-producing Human Lymphoid Lines by Preselection for Hapten Binding followed by EBV Transformation

23 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Tissue-specific expression and developmental regulation of the human fgr proto-oncogene

23 October 2022

64

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus

23 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes

23 October 2022

66

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line

23 October 2022

67

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells

23 October 2022

68

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.

23 October 2022

70

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Transformation of lymphocytes by Epstein-Barr virus requires only one-fourth of the viral genome

23 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association

23 October 2022

73

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain

23 October 2022

74

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Release of infectious Epstein-Barr virus by transformed marmoset leukocytes

23 October 2022

76

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus nuclear antigen forms a complex that binds with high concentration dependence to a single DNA-binding site

23 October 2022

77

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP

23 October 2022

78

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains

23 October 2022

79

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies

23 October 2022

80

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Phenotypic and Cytogenetic Characteristics of Human B-Lymphoid Cell Lines and Their Relevance for the Etiology of Burkitt'S Lymphoma

23 October 2022

81

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Molecular characterization of novel reciprocal translocation t(6;14) in an Epstein-Barr virus-transformed B cell precursor

23 October 2022

82

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Selective transformation of B lymphocytes by E.B. virus

23 October 2022

83

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins

23 October 2022

85

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1).

23 October 2022

86

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus

23 October 2022

87

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye

23 October 2022

88

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

23 October 2022

89

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

23 October 2022

90

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components

23 October 2022

91

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Negative control of DNA replication in composite SV40-bovine papilloma virus plasmids

23 October 2022

93

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Cis-acting negative control of DNA replication in eukaryotic cells

23 October 2022

94

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Infection of human B lymphocytes with high multiplicities of Epstein-Barr virus: Kinetics of EBNA expression, cellular DNA synthesis, and mitosis

23 October 2022

95

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1.

23 October 2022

98

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site

23 October 2022

101

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Biosynthesis and processing of the alpha subunit of the voltage-sensitive sodium channel in rat brain neurons.

23 October 2022

103

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons

23 October 2022

104

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

An Epstein-Barr virus transcript from a latently infected, growth-transformed B-cell line encodes a highly repetitive polypeptide

23 October 2022

106

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Adhesion receptors of the immune system

23 October 2022

107

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo

23 October 2022

108

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells.

23 October 2022

109

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Characterization of an antigen whose cell surface expression is induced by infection with Epstein-Barr virus

23 October 2022

112

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells

23 October 2022

114

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Sequence of a probable potassium channel component encoded at Shaker locus of Drosophila

23 October 2022

115

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck

23 October 2022

119

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Differences in human cell lines to support stable replication of Epstein-Barr virus-based vectors.

23 October 2022

120

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

23 October 2022

121

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

23 October 2022

123

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

23 October 2022

124

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

23 October 2022

125

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

A point mutation in the neu oncogene mimics ligand induction of receptor aggregation

23 October 2022

126

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6

23 October 2022

127

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes

23 October 2022

128

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes

23 October 2022

129

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor

23 October 2022

131

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

23 October 2022

133

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression

23 October 2022

135

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene

23 October 2022

136

1 reference

https://api.crossref.org/works/10.1016/S0065-3527(08)60276-6

23 October 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1659776

23 October 2022

1 reference